Deutsche Bank Aktiengesellschaft Reiterates Buy Rating for Diploma (LON:DPLM)

Diploma (LON:DPLMGet Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a note issued to investors on Friday, MarketBeat Ratings reports. They presently have a GBX 5,100 ($63.93) price objective on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 14.20% from the company’s current price.

Separately, Shore Capital cut shares of Diploma to a “hold” rating in a report on Tuesday, November 19th.

Check Out Our Latest Stock Report on DPLM

Diploma Price Performance

Shares of LON DPLM opened at GBX 4,466 ($55.99) on Friday. The business has a 50 day simple moving average of GBX 4,384.27 and a 200-day simple moving average of GBX 4,270.44. Diploma has a twelve month low of GBX 3,200 ($40.12) and a twelve month high of GBX 4,653 ($58.33). The company has a market capitalization of £5.99 billion, a price-to-earnings ratio of 5,193.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.27, a quick ratio of 0.80 and a debt-to-equity ratio of 45.69.

Insider Activity at Diploma

In related news, insider Johnny Thomson sold 26,794 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($56.86), for a total value of £1,215,375.84 ($1,523,600.15). Insiders own 0.52% of the company’s stock.

Diploma Company Profile

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Further Reading

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.